Metastatic behavior of breast cancer subtypes, J Clin Oncol Off J Am Soc Clin Oncol, vol.28, pp.3271-3278, 2010. ,
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases, Int J Radiat Oncol Biol Phys, vol.82, pp.2111-2118, 2012. ,
Survival of breast cancer patients with meningeal carcinomatosis, Ann Oncol Off J Eur Soc Med Oncol, vol.21, pp.2183-2190, 2010. ,
A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer, J Neurooncol, vol.113, 2013. ,
Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis, J Neurooncol, vol.114, 2013. ,
Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intracerebrospinal fluid chemotherapy, Clin Breast Cancer, vol.15, pp.66-72, 2015. ,
Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours, Ann Oncol Off J Eur Soc Med Oncol, vol.28, pp.84-99, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02940542
Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases, Cancer, vol.113, 2008. ,
Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER, Clin Cancer Res Off J Am Assoc Cancer Res, vol.17, 2011. ,
Risk factors for brain relapse in patients with metastatic breast cancer, Ann Oncol Off J Eur Soc Med Oncol, vol.15, pp.1640-1644, 2004. ,
The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma, Cancer, vol.101, pp.810-816, 2004. ,
Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer, Br J Cancer, vol.91, pp.639-682, 2004. ,
Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma, Cancer, vol.97, pp.2972-2979, 2003. ,
Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases, J Clin Oncol Off J Am Soc Clin Oncol, vol.27, pp.5278-86, 2009. ,
Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection, J Neurosurg, vol.116, pp.984-93, 2012. ,
Leptomeningeal metastasis after surgical resection of brain metastases, J Neurol Neurosurg Psychiatry, vol.66, pp.225-232, 1999. ,
Leptomeningeal disease and breast cancer: the importance of tumor subtype, Breast Cancer Res Treat, vol.146, pp.477-86, 2014. ,
Single nucleotide polymorphisms in DNA repair genes and putative cancer risk ,
, Arch Toxicol, vol.90, 2016.
Targeting the phosphoinositide 3-kinase pathway in cancer, Nat Rev Drug Discov, vol.8, pp.627-671, 2009. ,
PIK3R1 underexpression is an independent prognostic marker in breast cancer, BMC Cancer, vol.13, p.545, 2013. ,
PI3K and cancer: lessons, challenges and opportunities, Nat Rev Drug Discov, vol.13, pp.140-56, 2014. ,
The PI3K pathway as drug target in human cancer, J Clin Oncol Off J Am Soc Clin Oncol, vol.28, pp.1075-83, 2010. ,
Hallmarks of cancer: the next generation, Cell, vol.144, 2011. ,
A lipid kinase cousin cooperates to promote cancer, Cancer Cell, vol.19, 2011. ,
Inhibition of the p110a isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis, J Exp Med, vol.210, 2013. ,
PI3K in cancer-stroma interactions: bad in seed and ugly in soil, Oncogene, vol.33, pp.3083-90, 2014. ,
PTEN mediates the cross talk between breast and glial cells in brain metastases leading to rapid disease progression, Oncotarget, vol.8, pp.6155-68, 2017. ,
Targeting the phosphoinositide-3 (PI3) kinase pathway in breast cancer, Oncol, vol.16, 2011. ,
Frequent genetic alterations in EGFR-and HER2-driven pathways in breast cancer brain metastases, Am J Pathol, vol.183, 2013. ,
Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases, Breast Cancer Res BCR, vol.13, 2011. ,
Role for loss of nuclear PTEN in a harbinger of brain metastases, J Clin Neurosci Off J Neurosurg Soc Australas, vol.44, pp.148-54, 2017. ,
PI3K/PTEN/AKT/mTOR polymorphisms: association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximabdocetaxel, Head Neck, vol.37, pp.471-479, 2015. ,
Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy, J Clin Oncol Off J Am Soc Clin Oncol, vol.27, pp.857-71, 2009. ,
Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients, Carcinogenesis, vol.31, pp.1387-91, 2010. ,
Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with nonsmall cell lung cancer, Clin Cancer Res Off J Am Assoc Cancer Res, vol.19, 2013. ,
PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality, Int J Cancer, vol.126, pp.1121-1152, 2010. ,